The idea for the study initially bubbled up during a Fralin Biomedical Research Institute faculty retreat and was led by Warren Bickel, professor and director of the Addiction Recovery Research Center, who died in 2024
A series of 10 phase 3 multicenter, randomized clinical studies as part of the Peptide InnOvatioN for Early diabetes tReatment (PIONEER) program were conducted to compare the efficacy and safety of oral semaglutide with either placebo or active comparators [2131]
Here are some benefits that make GHK-Cu a sought-after molecule: 1
Oct 2024: A multi-society guidance (ASA, AGA, ASMBS, SAGES, etc.) concluded most patients can continue GLP-1s before elective surgery/endoscopy, with risk-stratified adjustments like liquid diet day prior, point-of-care gastric ultrasound, or brief hold for high-risk situations like active GI symptoms or rapid dose escalation
Glow BPC 157 10mg + GHK-CU 50mg + TB500 10mg Dosing & Observed Effects in Research In preclinical animal models, BPC 157 has been studied at doses ranging from 6 to 50 g/kg body weight using intraperitoneal, intramuscular, or oral routes